Simba Gill - Director at Serina Therapeutics, Inc.

Issuer-level insider activity

Identity 1 identity field
Entity type
Individual
SEC evidence 1 source field
Source evidence
Open source filing history

No buys or sells have been reported by Simba Gill since 01 Jun 2025

Reported holdings for Simba Gill in Serina Therapeutics, Inc.

Form 4 holding Director

Serina Therapeutics, Inc.

Security class
Stock Option (right to buy)
Shares / value
92,000
Estimated value
Report date
03 Feb 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Simba Gill in Serina Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .